Genetic predisposition to human infectious diseases;Prédisposition génétique aux maladies infectieuses humaines

Medecine Therapeutique

Volumn 6, Issue 10, 2000, Pages 786-797

  Abel, L ^a   Casanova, J L ^a  

^a Lab Genet Hum Malad Infectieuses   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; GENETIC PREDISPOSITION; HUMAN; INFECTION; INFECTION SENSITIVITY; LEPROSY; MYCOBACTERIOSIS; PARASITE VIRULENCE; PARASITOSIS; REVIEW; TUBERCULOSIS;

EID: 0034485983     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Immunogenetics in the analysis of resistance to intracellular pathogens
2. Mendelian susceptibility to mycobacterial infection in man
3. The impact of host genetics on susceptibility to human infectious diseases
4. Genetic epidemiology of infectious diseases in humans: Design of population-based studies
5. A comprehensive genetic map of the human genome based on 5 264 microsatellites
6. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome
7. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
8. Sequential tests for the detection of linkage
9. Familial disseminated atypical mycobacterial infection in childhood: A human mycobacterial susceptibility gene?
10. Immunological conditions of children with BCG disseminated infection
11. Idiopathic disseminated bacillus Calmette-Guerin infection: A French national retrospective study
12. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: Abnormal IL12 regulation
13. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
14. Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection
15. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection
16. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection
17. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency
18. A causative relationship between mutant IFNγR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child
19. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency
20. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: Mutational analysis and evaluation of therapeutic options
21. A novel form of complete IFNγR1 deficiency: Cell-surface receptors that do not bind IFNγ
22. Infections in IFNGR-1-deficient children
23. Inheritable defects in interleukin-12- and interferon-gamma-mediated immunity and the THl/TH2 paradigm in man
24. Inherited interferon gamma receptor deficiency
25. Viral infections in interferon-gamma receptor deficiency
26. Interferon-gamma receptor deficiency: An expanding clinical phenotype?
27. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis
28. Interferon-gamma receptor deficiency: Relationship between genotype, environment, and phenotype
29. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection
30. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guerin and Mycobacterium abscessus infection
31. Inherited interleukin-12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
32. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
33. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
34. IL12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men
35. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria
36. Leprosy
37. The immunology of leprosy: Speculations on the leprosy spectrum
38. Complex segregation analysis of leprosy in southern Vietnam
39. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade island
40. HLA and leprosy: A reevaluation
41. HLA class II immune response and suppression genes in leprosy
42. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy
43. HLA-linked genetic control of host response to Mycobacterium leprae
44. HLA-linked genes and leprosy: A family study in Karigiri, South India
45. HLA-linked control of predisposition to lepromatous leprosy
46. HLA-linked control of predisposition to lepromatous leprosy
47. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression
48. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg
49. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains
50. The Bcg/Ity/Lsh locus: Genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele
51. Genetic regulation of macrophage activation: Understanding the function of Nramp1 (= Ity/Lsh/Bcg)
52. Susceptibility to leprosy is linked to the human NRAMP1 gene
53. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families : No evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy
54. Genetic control of susceptibility to leprosy in French Polynesia; no evidence for linkage with markers on telomeric human chromosome 2
55. Granulomatous reaction to intradermal injection of lepromin (mitsuda reaction) is linked to the human NRAMP1 gene in vietnamese leprosy sibships
56. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions
57. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae
58. Association of vitamin D receptor genotype with leprosy type
59. Modeling the impact of global tuberculosis control strategies
60. Racial differences in susceptibility to infection by Mycobacterium tuberculosis
61. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective
62. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: Linkage study of the candidate genes NRAMP1 and TNFA
63. Association of an HLA-DQ allele with clinical tuberculosis
64. Influence of polymorphism in the genes for the interleukin IL1 receptor antagonist and IL-1 beta on tuberculosis
65. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
66. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene
67. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study
68. Time to put malaria control on the global agenda
69. Malaria pathogenesis
70. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8
71. Mouse loci for malaria-induced mortality and the control of parasitaemia
72. Common genetic disorders of the red cell and the « malaria hypothesis »
73. Malaria and red cell genetic defects
74. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
75. +-Thalassemia protects children against disease caused by other infections as well as malaria
76. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy
77. Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans
78. Common west African HLA antigens are associated with protection from severe malaria
79. Molecular analysis of the association of HLA-B53 and resistance to severe malaria
80. HLA class I-associated resistance to severe malaria: A parasitological reassessment
81. The immunogenetics of human infectious diseases
82. + CTL epitope in naturally exposed Kenyan adults
83. Association of malaria parasite population structure, HLA, and immunological antagonism
84. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
85. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
86. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
87. A polymorphism that affects OCT- 1 binding to the TNF promoter region is associated with severe malaria
88. Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups
89. Genetic regulation of human anti-malarial antibodies in twins
90. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens
91. Segregation analysis detects a major gene controlling blood infection levels in human malaria
92. Genetic control of blood infection levels in human malaria: Evidence for a complex genetic model
93. Human malaria: Segregation analysis of blood infection levels in a suburban area add a rural area in Burkina Faso
94. Linkage analysis of blood Plasmodium falciparum levels: Interest of the 5q31 -q33 chromosome region
95. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31 -q33
96. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33
97. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni
98. Full results of the genome-wide scan which localises a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33
99. Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni
100. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes
101. Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: Evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression
102. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene
103. Infection and disease in human schistosomiasis mansoni are under distinct major gene control